Department of Medical Oncology Ⅰ of FAHZU is a specialized department integrating medical treatment, teaching and scientific research. We have established a standard process for diagnosis, treatment and follow-up intending to emphasize the concept of standard of care, individualized and whole-process management. We have established a multidisciplinary team for medical care, education, research and application capable of systematic diagnosis and treatment skills in gastrointestinal, esophagus, head and neck cancer. As a clinical pharmacology base in oncology of the National Medical Products Administration (NMPA), we have hosted and participated in more than 100 global and domestic clinical trials including phase I,II,III study involving targeted therapy and immunotherapy. In addition, our researches focus on hotspots of novel agents, immune or targeted treatment, and conduct individualized treatment strategies based on novel technologies such as next-generation sequencing, liquid biopsy, patient-derived xenograft (PDX) and organoid models, thus to improve diagnosis technology and treatment efficiency.
As an accredited training base for doctoral and master's degrees in oncology, our department undertakes comprehensive educational responsibilities. These include supervising postgraduate oncology students, providing standardized residency training for internal medicine physicians, mentoring undergraduate medical students during their clinical clerkships, and offering advanced training programs for grassroots oncology specialists. To date, we have successfully trained over ten doctoral and master's graduates.
